Vaxess Technologies (United States)

Recent papers from Vaxess Technologies (United States)

1. Designing innovation ecosystems for biointelligent value creation – Identification of promising technology fields and pioneer countriesJournal of Open Innovation Technology Market and Complexity · 2025
2. Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adultsPLoS ONE · 2024
3. TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal CarcinomaInternational Journal of Molecular Sciences · 2023
4. Silk Fibroin Microneedle Patches for the Sustained Release of LevonorgestrelACS Applied Bio Materials · 2020
5. Stabilization of RNA Encapsulated in SilkACS Biomaterials Science & Engineering · 2018